Infectious Diseases in Patients with Diabetes Mellitus: Literature Review

Skryabina A. A.
Assistant, Chair for Department of Infectious Diseases and Epidemiology¹

Golenok E. S.
Student, Faculty of Medicine¹

Sobh M. M.
Student, Faculty of Medicine¹

1 - Pirogov Russian National Research Medical University, Moscow, Russia

Skryabina Anna Aleksandrovna; e-mail: anna.skryabina.85@mail.ru.

The study had no sponsorship.

None declared.

Diabetes mellitus is associated with increased susceptibility to infectious diseases. This is due to the fact that uncontrolled hyperglycemia is accompanied by impaired innate and adaptive immune response, micro- and macroangiopathies, neuropathy, and decreased urine antibacterial activity. Furthermore, complications of diabetes mellitus such as neuropathy and peripheral vascular disease can lead to skin ulceration with secondary bacterial infections. Bacteria can invade any organ of the human body, with the most common foci of infection in diabetes mellitus being the urinary tract, respiratory tract, skin, and soft tissues. Some infectious diseases are specific to patients with diabetes mellitus, such as malignant external otitis media, foot infections, and nasopharyngeal mucormycosis. Infectious processes may be the first manifestations of diabetes mellitus or provoking factors for inherent complications such as diabetic ketoacidosis and hypoglycemia. Glucose control can be an alternative tool in infection control not only in patients with diabetes mellitus. In addition, controlling hyperglycemia offers the potential to improve the outcome of some infectious diseases.

diabetes mellitus, DM, hyperglycemia, infectious diseases, mucormycosis, pneumonia

10.29234/2308-9113-2024-12-1-37-52

1. Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019; 157: 107843, doi: 10.1016/j.diabres.2019.107843

2. Abu-Ashour W., Twells L., Valcour J., Randell A., Donnan J., et al. The association between diabetes mellitus and incident infections: a systematic review and meta-analysis of observational studies. BMJ Open Diabetes Res Care. 2017; 5(1): e000336, doi: 10.1136/bmjdrc-2016-000336.

3. Frydrych L.M., Fattahi F., He K., Ward P.A., Delano M.J. Diabetes and sepsis: risk, recurrence, and ruination. Front Endocrinol (Lausanne) 2017; 8: 271, doi: 10.3389/fendo.2017.00271

4. Shaw J.E., Boulton A.J. The pathogenesis of diabetic foot problems: an overview. Diabetes 1997; 46 Supplement 2: S58-61, doi: 10.2337/diab.46.2.s58

5. Mirza B.A., Syed A., Izhar F., Ali Khan A. Bidirectional relationship between diabetes and periodontal disease: review of evidence. J Pak Med Assoc. 2010; 60(9): 766-768.

6. Cooke F.J. Infections in people with diabetes. Medicine 2019; 47(2) :110-113, doi: 10.1016/j.mpmed.2018.11.002

7. Pascale A., Marchesi N., Govoni S., Coppola A., Gazzaruso C. The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases. Curr Opin Pharmacol. 2019; 49: 1-5, doi: 10.1016/j.coph.2019.03.011

8. Clive S, Cockram C, Wong BCK. Diabetes and Infections. Textbook of Diabetes. Holt RI, Cockram C, Flyvbjerg A, Goldstein BJ (editors). John Wiley & Sons; 2017 Mar 6. 799-820.

9. Berbudi A., Rahmadika N., Tjahjadi A.I., Ruslami R. Type 2 Diabetes and its Impact on the Immune System. Curr Diabetes Rev. 2020; 16(5): 442-449, doi: 10.2174/1573399815666191024085838

10. Aleshina G.M. Nejtrofil'nye granulocity – fagocity, i ne tol'ko. [Neutrophilic granulocytes – phagocytes, and not only.] Medicinskij akademicheskij zhurnal [Medical Academic Journal] 2020; 20(4): 5-16. (In Russ.)

11. Serebrjanaja N.B., Kamran Sarkandi M. Purinergicheskaja reguljacija zashhitnyh reakcij pri infekcii Mycobacterium tuberculosis. [Purinergic regulation of defense responses during Mycobacterium tuberculosis infection.] Uspehi fiziologicheskih nauk [Advances in Physiological Sciences] 2022; 53(1): 3-15. (In Russ.)

12. Nikonova L.V., Tishkovskij S.V., Davydchik Je.V., Martinkevich O.N., Volkova E.T., et al. Osobennosti diagnostiki i lechenija iliopsoita u pacienta s saharnym diabetom. Sluchaj iz praktiki. [Features of diagnostics and treatment of iliopsoitis in a patient with diabetes mellitus. Case report.] Zhurnal Grodnenskogo gosudarstvennogo medicinskogo universiteta [Journal of Grodno State Medical University] 2021 19(5): 546-549. (In Russ.)

13. Popyhova Je.B., Stepanova T.V., Lagutina D.D., Kirijazi T.S., Ivanov A.N. Rol' saharnogo diabeta v vozniknovenii i razvitii jendotelial'noj disfunkcii. [Role of diabetes mellitus in the occurrence and development of endothelial dysfunction.] Problemy jendokrinologii [Problems of Endocrinology] 2020; 66(1): 47-55. (In Russ.)

14. Litvickij P.F., Sinel'nikova T.G. Vrozhdennyj immunitet: mehanizmy realizacii i patologicheskie sindromy. Chast' 3. [Congenital immunity: mechanisms of realization and pathological syndromes. Part 3.] Voprosy sovremennoj pediatrii [Issues in modern pediatrics] 2009; 8(3): 54-65. (In Russ.)

15. Gavrilova A.O., Severina A.S., Shamhalova M.Sh., Shestakova M.V. Rol' konechnyh produktov glikirovanija v patogeneze diabeticheskoj nefropatii. [The role of glycation end products in the pathogenesis of diabetic nephropathy.] Saharnyj diabet [Diabetes Mellitus] 2021; 24(5): 461-469. (In Russ.)

16. Ilyas R., Wallis R., Soilleux E.J., Townsend P., Zehnder D., et al. High glucose disrupts oligosaccharide recognition function via competitive inhibition: A potential mechanism for immune dysregulation in diabetes mellitus. Immunobiology 2010; 216: 126-131, doi: 10.1016/j.imbio.2010.06.002

17. Stegenga M.E., van der Crabben S.N., Dessing M.C., Pater J.M., van den Pangaart P.S., et al. Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med. 2008; 25: 157-164, doi: 10.1111/j.1464-5491.2007.02348.x

18. Spasov A.A., Rashhenko A.I. Terapevticheskij potencial razryvatelej poperechnyh sshivok glikirovannyh belkov. [Therapeutic potential of glycated protein cross-link breakers.] Vestnik Volgogradskogo gosudarstvennogo medicinskogo universiteta [Bulletin of Volgograd State Medical University] 2016; 1(57): 12-15. (In Russ.)

19. Graves D.T., Naguib G., Lu H., Leone C., Hsue H., et al. Inflammation is more persistent in type 1 diabetic mice. J Dent Res. 2005; 84: 324-328, doi: 10.1177/154405910508400406

20. Girard D., Vandiedonck C. How dysregulation of the immune system promotes diabetes mellitus and cardiovascular risk complications. Front Cardiovasc Med. 2022; 9: 991716, doi: 10.3389/fcvm.2022.991716

21. Chávez-Reyes J., Escárcega-González C.E., Chavira-Suárez E., León-Buitimea A., Vázquez-León P., et al. Susceptibility for Some Infectious Diseases in Patients with Diabetes: The Key Role of Glycemia. Front Public Health. 2021; 9: 559595, doi: 10.3389/fpubh.2021.559595

22. Cho Y.I., Mooney M.P., Cho D.J. Hemorheological disorders in diabetes mellitus. J Diabetes Sci Technol. 2008; 2(6): 1130-1138, doi: 10.1177/193229680800200622

23. Kukushkin G.V., Starostina E.G. Infekcii u bol'nyh saharnym diabetom (lekcija). [Infections in patients with diabetes mellitus (lecture).] RMZh [RMJ] 2016; 24(20): 1327-1333. (In Russ.)

24. Zelenina T.A., Zemljanoj A.B., Saluhov V.V., Ismailov D.D. Saharnyj diabet i infekcionnye zabolevanija. [Diabetes mellitus and infectious diseases.] Medicinskij vestnik MVD [Medical Bulletin of the Ministry of Internal Affairs] 2023; 122; 1(122): 30-38. (In Russ.)

25. Zemljanoj A.B., Zelenina T.A., Saluhov V.V., Gabaraeva N.R. Prognoz zazhivlenija posleoperacionnyh ran u bol'nyh s gnojno-nekroticheskimi formami sindroma diabeticheskoj stopy posle vypiski iz stacionara. [Prognosis of healing of postoperative wounds in patients with purulent-necrotic forms of diabetic foot syndrome after discharge from hospital.] Medicinskij vestnik MVD [Medical Bulletin of the Ministry of Internal Affairs] 2021; 5(114): 48-53. (In Russ.)

26. Van Veen K.E., Brouwer M.C., Van Der Ende A., Van De Beek D. Bacterial meningitis in diabetes patients: a population-based prospective study. Sci Rep. 2016; 15:6:36996, doi: 10.1038/srep36996

27. Pomar V., de Benito N., Mauri A., Coll P., Gurguí M., et al. Characteristics and outcome of spontaneous bacterial meningitis in patients with diabetes mellitus. BMC Infect Dis. 2020; 20(1): 292, doi: 10.1186/s12879-020-05023-5

28. Nikiforova G.N., Svistushkin V.M., Shevchik E.A., Zolotova A.V. Zlokachestvennyj naruzhnyj otit: sovremennye principy diagnostiki i lechenija. [Malignant external otitis: modern principles of diagnosis and treatment.] Vestnik otorinolaringologii [Otorhinolaryngology Bulletin] 2017; 82(1): 11-14. (In Russ.)

29. Carlton D.A., Perez E.E., Smouha E.E. Malignant external otitis: the shifting treatment paradigm. Am J Otolaryngol. 2018; 39(1) :41-45, doi: 10.1016/j.amjoto.2017.05.010

30. Bajsultanova R.Je.P., Rachina S.A., Suhorukova M.V., Ivanchik N.V. Vnebol'nichnaja pnevmonija u lic s saharnym diabetom: jepidemiologija, jetiologija, diagnostika, lechenie i profilaktika. [Community-acquired pneumonia in persons with diabetes mellitus: epidemiology, etiology, diagnosis, treatment and prevention.] Prakticheskaja pul'monologija [Practical Pulmonology] 2020; 1: 38-48. (In Russ.)

31. Di Yacovo S., Garcia-Vidal C., Viasus D., Adamuz J., Oriol I., et al. Clinical features, etiology, and outcomes of community-acquired pneumonia in patients with diabetes mellitus. Medicine (Baltimore) 2013; 92(1): 42-50, doi: 10.1097/MD.0b013e31827f602a

32. Zaharenkov I.A., Rachina S.A., Dehnich N.N., Kozlov R.S., Sinopal'nikov A.I. et al. Jetiologija tjazheloj vnebol'nichnoj pnevmonii u vzroslyh: rezul'taty pervogo rossijskogo mnogocentrovogo issledovanija. [Etiology of severe community-acquired pneumonia in adults: results of the first Russian multicenter study.] Terapevticheskij arhiv [Therapeutic Archive] 2020; 92(1): 36-42. (In Russ.)

33. Abe T., Eyituoyo H.O., De Allie G., Olanipekun T., Effoe V.S., et al. Clinical outcomes in patients with native valve infective endocarditis and diabetes mellitus. World J Cardiol. 2021;13(1):11-20, doi: 10.4330/wjc.v13.i1.11

34. Casqueiro J., Casqueiro J., Alves C. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocrinol Metab. 2012; 16 Suppl 1: S27-36, doi: 10.4103/2230-8210.94253

35. Ponomareva E.Ju., Kunicyna M.A. Infekcionnyj jendokardit u pacientov s saharnym diabetom. [Infectious endocarditis in patients with diabetes mellitus.] Klinicheskaja medicina [Clinical Medicine] 2021; 99(9-10): 548-553, doi: 10.30629/0023-2149-2021-99-9-10-548-553 (In Russ.)

36. Thomsen R.W., Jepsen P., Sørensen H.T. Diabetes mellitus and pyogenic liver abscess: risk and prognosis. Clin Infect Dis. 2007;44(9):1194-201, doi: 10.1086/513201

37. Li W., Chen H., Wu S., Peng J. A comparison of pyogenic liver abscess in patients with or without diabetes: a retrospective study of 246 cases. BMC Gastroenterol. 2018; 18(1):144, doi: 10.1186/s12876-018-0875-y

38. Shah B.R., Hux J.E. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003; 26(2): 510-513, doi: 10.2337/diacare.26.2.510

39. Mnif M.F., Kamoun M., Kacem F.H., Bouaziz Z., Charfi N., et al. Complicated urinary tract infections associated with diabetes mellitus: pathogenesis, diagnosis and management. Indian J Endocrinol Metab. 2013; 17(3): 442-445, doi: 10.4103/2230-8210.111637

40. Köves B., Cai T., Veeratterapillay R., Pickard R., Seisen T., et al. Benefits and Harms of Treatment of Asymptomatic Bacteriuria: A Systematic Review and Meta-analysis by the European Association of Urology Urological Infection Guidelines Panel. Eur Urol. 2017; 72(6): 865-868, doi: 10.1016/j.eururo.2017.07.014

41. Rusalenko M.G., Shevchenko N.I., Loginova O.P. Infekcii mochevyvodjashhih putej pri diabete: znachenie mikrobiologicheskogo monitoringa. [Urinary tract infections in diabetes: the importance of microbiologic monitoring.] Lechebnoe delo: nauchno-prakticheskij terapevticheskij zhurnal [Medical care: scientific and practical therapeutic journal] 2020; 2(72): 63-68. (In Russ.)

42. Nitzan O., Elias M., Chazan B., Saliba W. Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes Metab Synd Obes. 2015; 8: 129-136, doi: 10.2147/DMSO.S51792

43. Tan T.W., Shih C.D., Concha-Moore K.C., Diri M.M., Hu B., et al. Disparities in outcomes of patients admitted with diabetic foot infections. PLoS One. 2019; 14:e0211481, doi: 10.1371/journal.pone.0211481

44. Ndosi M., Wright-Hughes A., Brown S., Backhouse M., Lipsky B.A., et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med. 2018; 35: 78-88, doi: 10.1111/dme.13537

45. Ivanusa S.Ja., Risman B.V., Janishevskij A.V. Opyt lechenija sindroma diabeticheskoj stopy v klinike obshhej hirurgii Voenno-medicinskoj akademii im. S.M. Kirova. [Experience of treatment of diabetic foot syndrome in the clinic of general surgery of the Kirov Military Medical Academy.] Medicinskij vestnik GVKG im. N. N. Burdenko [Medical Bulletin of GVKG named after N. N. Burdenko] 2021; 5: 20-29, doi: 10.53652/2782-1730-2021-2-3(5)-20-29 (In Russ.)

46. Imankulova A.S., Kochorov O.T., Naraliev U.T. Osobennosti techenija gangreny Furn'e u pacientov s saharnym diabetom. [Features of Fournier’s gangrene in patients with diabetes mellitus.] Rany i ranevye infekcii. Zhurnal imeni prof. B.M. Kostjuchjonka [Wounds and wound infections. Journal of Prof. B.M. Kostyuchyonok] 2021; 8(1): 24-29. (In Russ.)

47. Morpurgo E., Galandiuk S. Fournier’s gangrene. Surg Clin North Am. 2002; 82(6): 1213-1224, doi: 10.1016/s0039-6109(02)00058-0

48. Thwaini A., Khan A., Malik A., Cherian J., Barua J., et al. Fournier’s gangrene and its emergency management. Postgrad Med J. 2006; 82(970): 516-519, doi: 10.1136/pgmj.2005.042069

49. Yaghan R.J., Al-Jaberi T.M., Bani-Hani I. Fournier’s gangrene. Dis Colon Rectum 2000; 43(9): 1300-1308, doi: 10.1007/BF02237442

50. Mtibaa L., Halwani C., Tbini M., Boufares S., Souid H., et al. Successful treatment of rhino-facial mucormycosis in a diabetic patient. Med Mycol Case Rep. 2020; 27: 64-67, doi: 10.1016/j.mmcr.2020.01.003

51. Khanna M., Challa S., Kabeil A.S., Inyang B., Gondal F.J., et al. Risk of Mucormycosis in Diabetes Mellitus: A Systematic Review. Cureus 2021; 13(10): e18827, doi: 10.7759/cureus.18827